UK Regulator Approves Second Alzheimer's Drug in Months but Government Won't Pay for It

Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost to taxpayers

aldoguerra851@gmail.com aldoguerra851@gmail.com
Oct 23, 2024 - 07:47
44 0
Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost to taxpayers
Read More